Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
Latest Information Update: 13 Feb 2026
At a glance
- Drugs AVB-114 (Primary)
- Indications Rectal fistula
- Focus Therapeutic Use
- Acronyms STOMP-II; STOMP2
- Sponsors Avobis Bio
Most Recent Events
- 29 Jan 2026 Results presented in an Avobis Bio media release Media Release.
- 29 Jan 2026 According to an Avobis Bio media release, data from this study to be presented in an oral presentation at the upcoming European Crohn's and Colitis Organisation (ECCO) Congress.
- 29 Oct 2025 According to Avobis Bio LLC media release, results from this trial were at a plenary session of the American College of Gastroenterology's Annual Scientific Meeting. The trial results were accepted as a late-breaking abstract and presented by Dr David A Schwartz, a STOMP2 investigator, Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition, and Department of Medicine, and Director of the Inflammatory Bowel Disease Center at Vanderbilt University Medical Center.